Page URL:

Gene linked to late-onset Alzheimer disease

7 March 2005
By BioNews
Appeared in BioNews 298

US researchers have identified a gene mutation linked to an increased risk of Alzheimer's disease. The team, based at the Massachusetts General Hospital, say that it is only the second gene ever to be linked to the late-onset form of the disorder. The results, published in the New England Journal of Medicine, are based on a study of 437 affected families.

Alzheimer's disease is caused by the gradual death of certain brain cells, especially in the areas involved in memory. Researchers have already identified mutations in four other genes that raise the risk of the disease. Three of these, which make the amyloid precursor, presenilin 1 and presenilin proteins, are involved in the rare, inherited form of Alzheimer's disease. The symptoms of early onset Alzheimer's appear before the age of 65, usually when someone is in their fifties, but sometimes sooner. The fourth gene variant, ApoE4, is linked to an increased risk of the more common, late onset form of the disorder.

In the latest study, the scientists focussed on a gene called ubiquilin-1, which makes a protein that interacts with presenilin 2. They found that in families with two affected relatives, variants of the ubiquilin-1 gene are significantly associated with late-onset Alzheimer's disease. The team, lead by Rudolph Tanzi, then looked at 217 pairs of siblings, in which one sibling had the disease but the other did not. The results confirmed that particular ubiquilin-1 variants occur more often in Alzheimer's disease patients than their unaffected siblings.

The researchers then studied brain tissue from both Alzheimer's patients and controls. They found that the gene variants linked to the disease resulted in increased production of a shorter form of the ubiquilin protein. 'Now we need to figure out what's wrong with too much ubiquilin-1 and with this different form', said Tanzi. It seems that the ubiqulin-1 variants raise the risk of Alzheimer's by about half as much as the ApoE4 variant does. The scientists say that there are probably another 4-7 additional gene variants to be found, each of which confers a similar level of risk.

Tanzi says his team already know that ubiquilin may have links to the slow build-up of 'plaques' - hallmark structures found in the brains of people with Alzheimer's disease. The plaques are clumps of a protein called beta-amyloid. 'I like to use a kitchen sink metaphor - you either make too much of it or you can't clear it away fast enough', said Tanzi, who thinks ubiquilin-1 may be involved in both processes. An article accompanying the study comments 'the role of the environment cannot be ignored', adding 'most disease is caused by a combination of genetic and environmental factors'.

Gene Mutation May Help Cause Alzheimer's |  3 March 2005
Genetic Factors in Alzheimer's Disease
NEJM |  3 March 2005
MGH study identifies potential Alzheimer's risk gene
Medical News Today |  3 March 2005
3 November 2008 - by Ailsa Stevens 
A study examining the genomes of more than 1,300 families has revealed four new genes potentially linked to the most common late-onset form of Alzheimer's disease, according to a study published in the American Journal of Human Genetics last week. The researchers, based at the Massachusetts General...
4 April 2007 - by Dr Jess Buxton 
According to the Sunday Times newspaper, a UK clinic is requesting permission to test embryos in order to select those free from early onset Alzheimer's disease. Charl and Danielle de Beer are planning undergo IVF treatment in conjunction with preimplantation genetic diagnosis (PGD) at the Bridge...
11 May 2006 - by Dr Jess Buxton 
The UK's fertility treatment regulator has given the go-ahead for couples to test embryos to avoid passing on hereditary cancer. At its open meeting held on 10 May in Belfast, the Human Fertilisation and Embryology Authority (HFEA) accepted a recommendation from its ethics and law committee...
13 February 2006 - by BioNews 
Alzheimer's disease (AD) is 'highly heritable', and genetic factors may also influence the timing of the condition, say US researchers. The team, based at the University of Southern California, studied 392 pairs of twins in which one or both had AD. Their results, published in the Archives of General Psychiatry...
10 November 2005 - by BioNews 
The UK's Human Fertilisation and Embryology Authority (HFEA) has launched a public debate on testing embryos for 'lower penetrance', late onset genetic disorders. A discussion paper, entitled 'Choices and Boundaries', focuses both on genetic tests currently available, such as that for hereditary breast cancer, and possible future developments, such as...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.